Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol

Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol

Background: Hepatic de novo lipogenesis (DNL) is ideally measured in very low-density lipoprotein (VLDL)-triacylglycerol (TAG). In the fasting state, the majority of plasma TAG typically represents VLDL-TAG; however, the merits of measuring DNL in total plasma TAG have not been assessed. This study...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Leanne Hodson, Sion A. Parry, Thomas Cornfield, Catriona Charlton, Wee Suan Low, Charlotte J. Green, Fredrik Rosqvist
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Upsala Medical Society 2020-07-01
Ráidu:Upsala Journal of Medical Sciences
Fáttát:
de novo lipogenesis
dnl
hepatic
human
triacylglycerol
vldl
Liŋkkat:http://dx.doi.org/10.1080/03009734.2020.1739789

Interneahtta

http://dx.doi.org/10.1080/03009734.2020.1739789

Geahča maid